PRO-DEX, INC. Contract with Customer, Asset, after Allowance for Credit Loss
PRO-DEX, INC. (PDEX) had Contract with Customer, Asset, after Allowance for Credit Loss of $70.00 thousand as of 2026-06-30, per its 10-K filed 2026-09-03.
Financial Statements › Balance Sheet › Assets
us-gaap:ContractWithCustomerAssetNet · last filed 2026-09-03
- 2026-06-30: Contract with Customer, Asset, after Allowance for Credit Loss $70.00K.
- 2026-03-31: Contract with Customer, Asset, after Allowance for Credit Loss $40.00K.
- 2025-12-31: Contract with Customer, Asset, after Allowance for Credit Loss $174.00K.
- 2025-09-30: Contract with Customer, Asset, after Allowance for Credit Loss $32.00K.
| Period end | Contract with Customer, Asset, after Allowance for Credit Loss | Contract with Customer, Asset, after Allowance for Credit Loss as first filed |
|---|---|---|
| 2026-06-30 | $70.00K 10-K · filed 2026-09-03 | |
| 2026-03-31 | $40.00K 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $174.00K 10-Q · filed 2026-04-30 | |
| 2025-09-30 | $32.00K 10-Q · filed 2026-01-29 | |
| 2025-06-30 | $24.00K 10-K · filed 2026-09-03 | |
| 2025-03-31 | $141.00K 10-Q · filed 2026-04-30 | |
| 2024-12-31 | $152.00K 10-Q · filed 2026-04-30 | |
| 2024-09-30 | $211.00K 10-Q · filed 2026-01-29 | |
| 2024-06-30 | $262.00K 10-K · filed 2026-09-03 | |
| 2024-03-31 | $331.00K 10-Q · filed 2025-05-01 | |
| 2023-12-31 | $412.00K 10-Q · filed 2025-05-01 | |
| 2023-09-30 | $591.00K 10-Q · filed 2025-01-30 | |
| 2023-06-30 | $494.00K 10-K · filed 2025-09-04 | |
| 2023-03-31 | $279.00K 10-Q · filed 2024-05-02 | |
| 2022-12-31 | $877.00K 10-Q · filed 2024-05-02 | |
| 2022-09-30 | $591.00K 10-Q · filed 2024-02-08 | $587.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $710.00K 10-K · filed 2024-09-05 | |
| 2022-03-31 | $341.00K 10-Q · filed 2023-05-04 | |
| 2021-12-31 | $424.00K 10-Q · filed 2023-05-04 | |
| 2021-09-30 | $185.00K 10-Q · filed 2023-02-02 | |
| 2021-06-30 | $193.00K 10-K · filed 2023-10-13 | |
| 2020-06-30 | $155.00K 10-K · filed 2022-09-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |